RELATED CONTENT
NEWS
- Focus on Almirall: partnering, new products and mature markets are key targets
- Genzyme yet to confirm date of next Fabrazyme shipment
- Roche expands hepatitis C deal with Merck after Victrelis' EU nod
- EU reprieve for Actos as CHMP concludes benefits outweigh risks in selected patients
FEATURES
Other Informa Features

